Clinical
Stent-less percutaneous coronary intervention using rotational atherectomy and drug-coated balloon: A case series and a mini review

https://doi.org/10.1016/j.carrev.2018.02.007Get rights and content

Highlights

  • Coronary revascularization therapy under DES-unsuitable conditions remains to be established.

  • Rotational atherectomy followed by drug-coated balloon dilation alone is proposed as a choice.

  • Optical frequency domain imaging is useful during the stent-less procedure.

Abstract

Background

Experiences of rotational atherectomy (RA) followed by drug-coated balloon (DCB) dilation alone (RA/DCB) for de novo coronary artery lesion have been limited.

Case series

Case 1 (65 year-old male) with silent myocardial ischemia and hemodialysis had old anterior myocardial infarction and intact LM/LCx, and underwent RA/DCB against a diffuse calcified lesion in the proximal LAD and a tandem lesion in the proximal RCA. Case 2 (88 year-old female) with post-infarction unstable angina had severe thrombocytopenia and anemia due to myelodysplastic syndrome (platelet 6000/μL, hemoglobin 8.3 g/dL), and underwent RA/DCB against a severe stenosis in the mid LCx after transfusions. Case 3 (47 year-old male) with silent myocardial ischemia due to possible sequelae of Kawasaki disease underwent RA/DCB against a restenotic lesion at the in-let of the calcified aneurysm in the proximal LAD. In all of the patients, PCI was successfully completed under optical frequency domain imaging (OFDI) without complications. Follow-up CAG performed 6–7 months after the procedure revealed no restenosis in case 1 and case 3, and all of the 3 cases have been free of cardiovascular/hemorrhagic events for 11–37 months since the last stent-less procedures.

Conclusions

These cases suggest that RA/DCB under OFDI might be an alternative stent-less revascularization therapy of choice for patients who may be unsuitable for drug-eluting stent implantation.

Introduction

Implantation of drug-eluting stent (DES) has been a mainstay of the interventional treatment of coronary artery disease (CAD); however, there still remain several clinical conditions, in which DES implantation is inappropriate, such as calcified diffuse lesion, bleeding tendency, metal allergy, and coronary sequelae of Kawasaki disease (KD). For CAD patients under those specific status, percutaneous coronary intervention (PCI) without stenting “stent-less PCI” is theoretically a suitable revascularization therapy. Nowadays drug-coated balloon (DCB) for de novo coronary artery lesions has attracted more attention, and pre-treatment with rotational atherectomy (RA) followed by DCB dilation (RA/DCB) might be a promising option of stent-less PCI [[1], [2], [3]]. In this mini-review, we have focused on utility of the stent-less PCI using RA/DCB under the DES-unsuitable conditions in a case series.

Section snippets

Case 1: Calcified diffuse lesion in hemodialysis

Hemodialysis is an established risk factor of DES failure, such as target lesion revascularization (TLR) and late stent thrombosis [4,5], and calcified diffuse lesion is one of the characteristics of coronary involvement in patients with hemodialysis.

A 65-year-old man with silent myocardial ischemia and hemodialysis had old anterior myocardial infarction, a calcified diffuse lesion in the proximal left anterior descending coronary artery (LAD), a tandem lesion in the proximal right coronary

Discussion

As a primary interventional treatment for in-stent restenosis, usefulness of DCB has already been established [12]. In contrast, for de novo coronary artery lesions, no proved facts supporting superiority of DCB over DES have been available; however, several registries and small-sized randomized controlled trials comparing with DES have indicated acceptable results regarding safety and efficacy of DCB particularly among small vessel de novo lesions [[13], [14], [15], [16]]. In the DCB-alone

Conclusion

Stent-less PCI using RA followed by DCB dilation under OFDI could be a candidate of revascularization therapy for CAD patients complicated with DES-unavailable conditions.

The following are the supplementary data related to this article.

. Case 1 Pre-procedural (Panel A, B, equivalent to Panel I, J in Fig. 2, respectively), post-ablation with 1.75 mm burr (Panel C, D, corresponding to Panel A, B, respectively), post-ablation with 2.0 mm burr (Panel E, F, corresponding to Panel A, B, respectively),

Disclosures

The authors have no conflicts of interest regarding the content of the manuscript.

References (21)

There are more references available in the full text version of this article.

Cited by (11)

  • Stentless Interventional Procedure Using Rotational Atherectomy and Drug-Coated Balloon for Noncalcified De Novo Lesions

    2021, CJC Open
    Citation Excerpt :

    Indeed, accumulating reports have already shown that 1-month DAPT is feasible for non-acute coronary syndrome patients receiving DCB treatments.15,20,21 Moreover, for high bleeding risk patients undergoing DCB-alone treatment, very short (< 1 month) DAPT or single antiplatelet therapy might be appropriate, from the viewpoint of risks of bleeding complications and coronary thrombosis.11,19 However, recent clinical trials have indicated feasibility of 1-month DAPT among patients receiving drug-coated stent or DES.22-24

  • Angiographic and Clinical Outcomes After Stent-less Coronary Intervention Using Rotational Atherectomy and Drug-Coated Balloon in Patients with De Novo Lesions

    2020, Cardiovascular Revascularization Medicine
    Citation Excerpt :

    Moreover, a very recent report from Japanese investigators has demonstrated that among patients undergoing PCI using cobalt‑chromium everolimus-eluting stent, 1-month DAPT followed by clopidogrel monotherapy is noninferior to 12-month DAPT in cardiovascular events, and superior to 12-month DAPT in bleeding events [26]. However, in patients with very high-bleeding risks such as gastrointestinal cancer or severe thrombocytopenia, even 1-month DAPT might not be tolerated, and stent-less PCI under shorter-term (<1 month) DAPT or single antiplatelet therapy might be theoretically a suitable revascularization therapy for those patients [3,12]. Stent-less RA/DCB procedure is an alternative interventional treatment of choice for CAD patients who may be unsuitable for DES implantation.

  • Potent Stent-Less Procedure Using Rotational Atherectomy and Drug-Coated Balloon to Right Coronary Ostial Lesion

    2019, Cardiovascular Revascularization Medicine
    Citation Excerpt :

    Even in the DES era, the RCA ostial lesion still therefore remains therapeutic challenge for interventional cardiologists. Nowadays stent-less percutaneous coronary intervention (PCI) using rotational atherectomy (RA) followed by drug-coated balloon (DCB) dilation (RA/DCB) under DES-unsuitable conditions has gained more interest [4–7]. In this mini-review, we have focused on utility of the stent-less PCI using RA/DCB for the RCA ostial lesion in a case series.

  • Surgical treatment of coronary artery lesions caused by Kawasaki disease

    2021, Chinese Journal of Applied Clinical Pediatrics
  • Hybrid rotablation and drug-eluting balloon strategy

    2021, Cardiovascular Journal of Africa
View all citing articles on Scopus
View full text